| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |